Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
06/2007
06/21/2007US20070142407 Benzo (1,2,5) thiadiazole als crf-antagonisten
06/21/2007US20070142400 Enantjomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
06/21/2007US20070142375 Pyrrolidine derivatives as factor xa inhibitors
06/21/2007US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
06/21/2007US20070142373 Quinoline derivatives as phosphodiesterase inhibitors
06/21/2007US20070142352 Pteridinone Derivatives as Modulators of Chemokine Receptor Activity
06/21/2007US20070142342 Pharmaceutical compounds
06/21/2007US20070142341 Use of steroid derivatives for the treatment of angiotensin ll related disease e.g. cardiovascular and proliferative disorders
06/21/2007US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ
06/21/2007US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine
06/21/2007US20070142314 Administering a nucleotide decoy of an ets gene or a chimera decoy of NF-Kappa B with a hydrophillic polymer carrier sheet; aneurysm, Marfan's syndrome, aortic detachment, and plaque rupture
06/21/2007US20070142294 Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade
06/21/2007US20070142280 Factor VII or VIIa-like molecules
06/21/2007US20070140987 Promoting whole body health
06/21/2007US20070140978 Adrenergic complement inhaler
06/21/2007DE102005059602A1 Verfahren zur Mikronisierung Process for the micronization
06/21/2007CA2633374A1 Amine compound and use thereof for medical purposes
06/21/2007CA2631949A1 Micronization method for preparing virtually anhydrous tiotropium bromide monohydrate
06/21/2007CA2631342A1 Novel n-(fluoro-pyrazinyl)-phenylsulfonamid.es as moodulators of chemokine receptor ccr4.
06/21/2007CA2631051A1 Organic compounds
06/20/2007EP1798230A1 Substituted alkylamine derivatives and methods of use
06/20/2007EP1798229A1 Substituted biphenyl derivative
06/20/2007EP1798226A1 Triazole derivative
06/20/2007EP1798221A1 2-arylcarboxamide-nitrogeneous heterocycle compound
06/20/2007EP1797878A2 Benzothiazole derivatives
06/20/2007EP1797082A1 Carbostyril compound
06/20/2007EP1797040A1 Muscarinic receptor antagonists
06/20/2007EP1796699A1 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children.
06/20/2007EP1796679A1 Ciclesonide and syk inhibitor combination and methods of use thereof
06/20/2007EP1796653A2 Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
06/20/2007EP1594517B1 Compositions for the treatment of gastrointestinal disorders
06/20/2007EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
06/20/2007EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
06/20/2007EP1272204B1 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
06/20/2007EP1137439B1 Stabilization of rapamycins or derivatives of rapamycins
06/20/2007CN1984914A Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as protein kinase ingibitor
06/20/2007CN1984905A Constrained himbacine analogs as thrombin receptor antagonists
06/20/2007CN1984658A Opioids for the treatment of the chronic obstructive pulmonary disease (COPD)
06/20/2007CN1984656A Cancer treatment method
06/20/2007CN1984653A Combinations of inhibin with bronchodilators
06/20/2007CN1984642A Aerosol suspension formulations containing TG 227 ea or TG 134 a as a propellant
06/20/2007CN1984638A Powder formulations for inhalation, comprising enantiomerically pure beta-agonists
06/20/2007CN1982308A Substituted pyrazoles
06/20/2007CN1981859A Chinese-medicinal extract with liver-clearing and phlegm-resolving functions and its production
06/20/2007CN1981838A Chinese medicine for treating rhinopathia and nose cancer, its making and using method
06/20/2007CN1981782A Production of larynx-moistening amino-bee glue fluid
06/20/2007CN1981777A Chinese medicinal preparation for treating cardio vascular diseases, its making method and use
06/20/2007CN1981769A Hydrochloride epinastine dispersing tablets and their production
06/20/2007CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
06/20/2007CN1322007C Antibacterial peptide DC and its preparing process and use
06/20/2007CN1321996C Process for preparing 2-iminopyrrolidine derivatives
06/20/2007CN1321981C New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same
06/20/2007CN1321695C Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
06/20/2007CN1321690C Use of recommbined human lysozyme in preparation of medicine for bronchial asthma
06/20/2007CN1321665C Combination of medication by using beartyberry and dragon's blood resin as combination of activities
06/20/2007CN1321659C Throat benefiting detoxication prepn
06/20/2007CN1321657C Buccal tablets for curing acute or chronic pharyngitis and buccal inflammation and the preparation technology thereof
06/19/2007US7232909 Pyridine derivatives
06/19/2007US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents
06/19/2007US7232835 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists
06/19/2007US7232815 Dibenzo[b.f]oxazolo-azulines, -oxepines and -thiepines; antiinflammatories; analgesics
06/19/2007US7232680 For producing vaccine for protecting a mammal or a bird from infection by a Nidovirales virus
06/19/2007US7232564 Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections
06/19/2007US7232562 E38N interferon gamma polypeptide variants
06/19/2007CA2437468C Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
06/19/2007CA2281844C Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
06/19/2007CA2276429C Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant
06/14/2007WO2007068007A1 Use of a disinfectant for treating respiratory tract infections
06/14/2007WO2007067966A1 Method and formula for prevention of cold and flu and suppression of related symptoms
06/14/2007WO2007066823A1 Antibody against connective tissue growth factor or composition containing the same
06/14/2007WO2007066068A2 Calcium ion channel receptor antagonist
06/14/2007WO2007065451A1 Means for preventing and treating rhinitis of different ethiology, method for the production thereof, a pharmaceutical composition based thereon and a preventing and treating method
06/14/2007WO2007044560A3 Modulators of atp-binding cassette transporters
06/14/2007WO2007039111A3 Novel multi-cyclic compounds and their use
06/14/2007WO2006120580A3 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
06/14/2007US20070135508 e.g. (2(2S)-(1 alpha , 5 alpha , 6 alpha )-6-N-[3-benzyl-3-azabicyclo[3.1.0]-hexyl]-2-[(1R or 1S)-3-oxocyclohexyl]-2-hydroxy-2-phenylacetamide; respiratory, urinary and gastrointestinal systems disorder; antidiabetic agent
06/14/2007US20070135502 Heterocyclic compounds and methods of use
06/14/2007US20070135482 Substituted pyrrolidine and related compounds
06/14/2007US20070135478 3-(2-Benzyl-2-hydroxy-3-phenyl-propylidene)-8,8-dimethyl-8-azonia-bicyclo[3.2.1]octane iodide; muscle relaxants, respiratory system disorders; asthma, bronchitis, chronic obstructive lung disease, chronic bronchitis, chronic respiratory obstruction, pulmonary fibrosis, pulmonary fibrosis
06/14/2007US20070135458 6-Substituted pyrido-pyrimidines
06/14/2007US20070135404 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia
06/14/2007US20070135402 Azetidine ring compounds and drugs comprising the same
06/14/2007US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases
06/14/2007DE102006051512A1 Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin Pharmaceutical compositions medication with cyclosporine
06/14/2007CA2838111A1 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
06/13/2007EP1795203A2 Fhit proteins and nucleic acids and methods based thereon
06/13/2007EP1795192A2 1-Substituted imidazole derivatives as nos inhibitors
06/13/2007EP1794160A1 6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as proteine kinase inhibitors
06/13/2007EP1794154A1 Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases
06/13/2007EP1794147A1 Compounds
06/13/2007EP1793856A2 Methods and compositions for treating allergic inflammation
06/13/2007EP1793847A2 Use of microproteins as tryptase inhibitors
06/13/2007EP1519908B1 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
06/13/2007EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors
06/13/2007EP1456219B1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist
06/13/2007EP1455810B1 Pharmaceutical formulation comprising cyclosporin and use thereof
06/13/2007EP1339737B1 Immunomodulatory protein derived from the yaba monkey tumor virus
06/13/2007EP1337512B1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
06/13/2007EP1276474B1 Formulations for use in inhaler devices
06/13/2007EP1220679B1 Cell-based gene therapy for the pulmonary system